ASX: ACW - Xanamem Clinical Development & Investor Update.

Tuesday, July 2, 2019 10:00 PM +00:00

ASX: ACW - Xanamem Clinical Development & Inv...0:0010:09
LIVEQuality1  AudioSubtitleDownloadSpeed1  
ACTINOGEN LIMITED
Bill Ketelbey

Actinogen Medical (ASX: ACW) is pleased to provide an update on the progress the Company is making with the ongoing clinical development program for Xanamem™. This update should be read in conjunction with the latest investor presentation.


Leave a Comment

Your email address will not be published

WEBCAST Calendar

  • 20 Jan

    00:30

    Q4 2019 Schlumberger Earnings Conference Call 17 January 2020

    SCHLUMBERGER N.V.
  • 20 Jan

    00:30

    Oventus Medical Limited, sleep treatment platform roll-out

    OVENTUS MEDICAL LIMITED
  • 20 Jan

    02:00

    Fastenal Company Annual & Fourth Quarter 2019 Earnings Results Conference Call 17 January 2020

    FASTENAL COMPANY
  • 20 Jan

    02:00

    Investor Stream chats with: Indiana Resources Non-Executive Chair Bronwyn Barnes 17 January 2020

    INDIANA RESOURCES LIMITED
  • 20 Jan

    02:00

    Brandon Munro - When the Needle Starts Clickin' it's Where I'm Gonna Dig

    BANNERMAN RESOURCES LIMITED